Search results

Jump to navigation Jump to search
Did you mean: with releasing agent

  • Methamphetamine
    76 (8): 1169–1174. ISSN 0002-838X.  https://en.wikipedia.org/wiki/Monoamine_releasing_agent#Activity_profiles Kirkpatrick, M. G., Gunderson, E. W., Johanson
    41 KB (5,798 words) - 13:29, 16 April 2024
  • Main Page (section Please don't crawl the wiki. Use our API instead.PsychonautWiki ❤️ Developers. Please report any obstacles.)
    Opioid ⋅ Phenethylamine ⋅ Research chemicals ⋅ Reuptake inhibitor ⋅ Releasing agent ⋅ Substituted amphetamine ⋅ Substituted cathinone ⋅ Substituted pyrrolidine
    21 KB (1,004 words) - 23:38, 13 May 2024
  • 4-FA
    fluorinated analogue of amphetamine. 4-Fluoroamphetamine acts as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine producing
    21 KB (3,439 words) - 15:42, 30 July 2022
  • Research chemicals
    drugs such as MAOIs, RIMAs, stimulants and any substance which act as a releasing agent or reuptake inhibitor of neurotransmitters such as serotonin and dopamine
    19 KB (2,209 words) - 23:08, 21 April 2024
  • Stimulants
    signalling act as reuptake inhibitors (NDRIs, e.g. methylphenidate), releasing agents (NDRAs, e.g. amphetamine) or receptor ligands (e.g yohimbine). Stimulants
    11 KB (1,055 words) - 02:52, 12 May 2024
  • 6-APB
    (SERT), respectively. 6-APB also possesses additional activity as a releasing agent of these monoamine neurotransmitters. 6-APB is a potent full agonist
    33 KB (4,870 words) - 14:34, 16 April 2024
  • MDA
    primarily as a serotonin-norepinephrine-dopamine reuptake inhibitor and releasing agent.[citation needed] However, MDA is significantly more potent by weight
    31 KB (4,379 words) - 12:23, 6 May 2024
  • MDAI
    acts as a putatively non-neurotoxic and highly selective serotonin releasing agent (SSRA) with neglible effects on dopamine and norepinephrine. MDAI was
    17 KB (2,560 words) - 07:40, 12 October 2023
  • MDMA
    methylated analog of the hemostatic agent hydrastinine. There are no indications of interest in MDMA as an active agent itself. It was not mentioned again
    85 KB (10,499 words) - 14:24, 16 April 2024
  • Amphetamine
    Additionally, it sees widespread illicit use as a performance enhancing agent and recreational substance. Subjective effects include stimulation, focus
    41 KB (5,610 words) - 19:01, 7 April 2024
  • Scientific information
    content listed within this portal. Agonist Antagonist Reuptake inhibitor Releasing agent Inverse agonist Positive allosteric modulator Negative allosteric modulator
    599 bytes (162 words) - 23:00, 21 April 2024
  • Cyclazodone
    function. There is no evidence that releasing agents are directly neurotoxic in humans. However, large doses of releasing agents may cause indirect neurotoxicity
    19 KB (2,675 words) - 16:54, 31 March 2024
  • 4-FMA
    structural analog 4-FA, 4-Fluoromethamphetamine is thought to act as a releasing agent and reuptake inhibitor of dopamine, serotonin, and norepinephrine, producing
    21 KB (3,467 words) - 16:14, 30 July 2022
  • 6-APDB
    this furan ring with 5-APDB, 5-MAPDB and 6-MAPDB. 6-APDB acts as a releasing agent and triple reuptake inhibitor of the monoamine neurotransmitters known
    26 KB (4,015 words) - 23:44, 21 April 2024
  • ΑMT
    psychedelic αMT acts as a relatively balanced reuptake inhibitor and releasing agent of the main three monoamines; serotonin, norepinephrine, and dopamine
    25 KB (2,825 words) - 16:14, 28 November 2022
  • Tramadol
    noradrenaline reuptake. Tramadol acts as an opioid receptor agonist, serotonin releasing agent, norepinephrine reuptake inhibitor, NMDA receptor antagonist, 5-HT2C
    22 KB (3,211 words) - 19:11, 7 April 2024
  • Methylphenidate
    methylphenidate is a dopamine reuptake inhibitor while amphetamine is both a releasing agent and reuptake inhibitor of dopamine and norepinephrine. Each of these
    31 KB (4,254 words) - 15:15, 6 May 2024
  • Clonidine
    clonidine first saw clinical use in 1966. As the first anti-hypertensive agent with a clearly identifiable central site of action, clonidine has been an
    22 KB (2,932 words) - 13:49, 16 April 2024
  • Aniracetam
    Referan, and systematically as N-anisoyl-2-pyrrolidinone) is a nootropic agent belonging to the racetam family of drugs. Although it is one of the first
    11 KB (1,427 words) - 22:01, 24 January 2024
  • 3-MeO-PCP
    MDMA: 3-MeO-PCP acts as a mild serotonin releasing agent and could interact negatively with the serotonin release of MDMA Austria: 3-MeO-PCP is illegal to
    25 KB (3,520 words) - 21:44, 6 May 2024

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)

Retrieved from ‘https://psychonautwiki.org/wiki/Special:Search’